Immunomediated Diseases and Innovative Therapies

Overview

The Immunomediated Diseases and Innovative Therapies is a heterogeneous area composed by both translational and clinical research groups which cover fields such as immunology, respiratory and systemic diseases, pharmacology, clinical biochemistry, rheumatology, advanced therapies or transfusional medicine. Its main strength derives precisely from this heterogeneity and the complementarity of the scientific interests and expertise of the different groups, many of which are currently joining efforts and synergizing in a variety of collaborative research projects.

Publications

229

total

1430

impact factor

6.25

average impact factor

Group Leader: Luisa Ibáñez

team

zoom

download

The group is a Special Group of Research recognized by AGAUR GenCat. The participation in the “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” has been renewed. Within this consortium two new studies started “Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends” EMA/2017/09/PE (Lot 4) and “Impact of EU label changes and revised pregnancy prevention programme for medicinal products containing valproate: utilisation and prescribing trends” EMA/2017/09/PE (Lot 4)

A new collaborative project has been awarded with the allergy service. A new twitter account @CFVCAT has started to inform about medicines and their adverse events.The group continues the international training activities through its participation in the European master of pharmacoepidemiology (Eu2P) and hosting fellow researchers. New projects have requested the research supporting tasks of W3Nexus FICF group on standardized reporting forms and an on-line database.

Immunomediated Diseases and Innovative Therapies

Overview

Publications

Group Leader: Luisa Ibáñez

Research Areas